Education
About Us
Working with TipRanks
Follow Us
Artivion (AORT)
NYSE:AORT
AORT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$21.97 - $32.94
Previous CloseN/A
Volume97.41K
Average Volume (3M)317.81K
Market Cap
$1.34B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.97
Next Earnings
Aug 07, 2025EPS Estimate
>-0.01Last Dividend Ex-Date
Dec 09, 2015Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding42,702,785
10 Day Avg. Volume255,806
30 Day Avg. Volume317,813
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$33.00Price Target Upside5.40% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Bulls Say, Bears Say
Bulls Say
Growth OpportunitiesThe company's bets on the aortic arch repair space, including acquisitions and distribution options, are on the verge of paying off, indicating potential growth.
Operational RecoveryDespite the cybersecurity attack, Artivion is now operating near full capacity and expects significant revenue growth in the year.
Product ApprovalThe earlier-than-expected approval of the AMDS humanitarian-device-exemption is anticipated to positively contribute to 2025 top-line growth.
Bears Say
Cybersecurity ImpactThe December cybersecurity breach led to lower-than-expected 4Q24 sales, impacting the company's financial performance.
Financial ProjectionsThe price target was lowered to $32 from $34, given the cybersecurity issue.
Revenue ChallengesQ1 is expected to continue feeling the impact of the cybersecurity incident, affecting revenue recognition.
Artivion News
AORT FAQ
What was Artivion’s price range in the past 12 months?
Artivion lowest stock price was $21.97 and its highest was $32.94 in the past 12 months.
What is Artivion’s market cap?
Artivion’s market cap is $1.34B.
When is Artivion’s upcoming earnings report date?
Artivion’s upcoming earnings report date is Aug 07, 2025 which is in 8 days.
How were Artivion’s earnings last quarter?
Artivion released its earnings results on May 05, 2025. The company reported -$0.01 earnings per share for the quarter, beating the consensus estimate of -$0.121 by $0.111.
Is Artivion overvalued?
According to Wall Street analysts Artivion’s price is currently Undervalued.
Does Artivion pay dividends?
Artivion pays a Quarterly dividend of $0.03 which represents an annual dividend yield of N/A. See more information on Artivion dividends here
What is Artivion’s EPS estimate?
Artivion’s EPS estimate is >-0.01.
How many shares outstanding does Artivion have?
Artivion has 42,702,785 shares outstanding.
What happened to Artivion’s price movement after its last earnings report?
Artivion reported an EPS of -$0.01 in its last earnings report, beating expectations of -$0.121. Following the earnings report the stock price went up 15.355%.
Which hedge fund is a major shareholder of Artivion?
Currently, no hedge funds are holding shares in AORT
Artivion Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$33.00 (5.40% Upside)
$33.00 (5.40% Upside)
Blogger Sentiment
Bullish
AORT Sentiment 70%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 211.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $922.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.4%
Last 30 Days ▼ 11.2%
Last 30 Days ▼ 11.2%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
13.93%
12-Months-Change
Fundamentals
Return on Equity
-7.25%
Trailing 12-Months
Asset Growth
0.91%
Trailing 12-Months
Company Description
Artivion
Artivion, Inc. (AORT) is a medical device company that specializes in developing, manufacturing, and distributing innovative technologies for cardiac and vascular surgery. The company operates primarily in the healthcare sector, focusing on life-saving medical solutions for patients with aortic diseases. Artivion's core products include surgical sealants, cryopreserved cardiac and vascular tissues, and mechanical heart valves, which are used by surgeons and healthcare providers worldwide.
AORT Company Deck
AORT Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Artivion's earnings call highlighted strong revenue growth in key product lines and geographical regions, along with a successful launch of the AMDS product. However, challenges such as the impact of a cybersecurity incident and a decline in North American revenue were noted. Nevertheless, the overall outlook remains optimistic with raised revenue guidance and positive clinical data supporting future growth.Read More>AORT Stock 12 Month Forecast
Average Price Target
$33.00
▲(5.40%Upside)
Technical Analysis
Ownership Overview
5.50% Insiders
34.16% Mutual Funds
0.03% Other Institutional Investors
39.18% Public Companies and
Individual Investors